SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 93 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2014. The put-call ratio across all filers is 1.91 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $69,000 | +1280.0% | 266,021 | +1178.7% | 0.00% | – |
| Q1 2016 | $5,000 | -54.5% | 20,804 | -34.8% | 0.00% | – |
| Q4 2015 | $11,000 | -80.4% | 31,921 | -0.5% | 0.00% | – |
| Q3 2015 | $56,000 | -83.5% | 32,096 | -78.9% | 0.00% | – |
| Q2 2015 | $340,000 | +163.6% | 152,188 | +128.8% | 0.00% | – |
| Q1 2015 | $129,000 | -69.5% | 66,513 | -58.3% | 0.00% | – |
| Q4 2014 | $423,000 | -30.4% | 159,616 | -21.1% | 0.00% | – |
| Q3 2014 | $608,000 | -39.0% | 202,420 | -16.9% | 0.00% | -100.0% |
| Q2 2014 | $996,000 | +9.2% | 243,479 | +15.1% | 0.00% | 0.0% |
| Q1 2014 | $912,000 | -5.4% | 211,497 | +14.9% | 0.00% | 0.0% |
| Q4 2013 | $964,000 | +13.3% | 183,997 | +36.3% | 0.00% | 0.0% |
| Q3 2013 | $851,000 | -33.1% | 134,970 | -47.1% | 0.00% | 0.0% |
| Q2 2013 | $1,272,000 | +33.9% | 255,004 | +130.9% | 0.00% | 0.0% |
| Q1 2013 | $950,000 | – | 110,446 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 37,061,186 | $82,646,000 | 87.47% |
| Geller Advisors LLC | 187,323 | $418,000 | 0.24% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 430,749 | $961,000 | 0.22% |
| Verity Asset Management, Inc. | 81,694 | $182,000 | 0.16% |
| CAXTON CORP | 52,000 | $116,000 | 0.12% |
| Catalyst Capital Advisors LLC | 400,000 | $892,000 | 0.10% |
| Cutler Capital Management, LLC | 72,500 | $161,000 | 0.07% |
| STONERIDGE INVESTMENT PARTNERS LLC | 239,202 | $533,000 | 0.07% |
| SECOR Capital Advisors, LP | 35,087 | $78,000 | 0.03% |
| Roundview Capital LLC | 29,100 | $65,000 | 0.02% |